Plant Growth Promoting Rhizobacteria (PGPR) are soil bacteria that can stimulate plant growth by supplying substances that are usually in limited quantities in the soil especially phosphorous, nitrogen and growth hormone such as indole acetic acid (AIA). These bacteria can also slow the growth of plant pathogens through the production of several antimicrobial metabolites. To investigate the role of rhizobacteria as a biostimulant agent a novel bacterium B8, isolated from the rhizospheric soil of medlar (Mespilus germanica L.- Family Rosaceae), was evaluated on Brassica napus and Medicago sativa. In addition to the classical methods of identification (physiological and biochemical tests), B8 was identified by 16S rRNA gene sequencing as Bacillus clausii. The ability of the strain to produce lytic enzymes such as cellulases, chitinases, pectinases, and phospholipases was studied. Furthermore, the strain B8 was tested for the capability to produce plant growth metabolites like phosphatases and phytases in order to solubilize inorganic phosphate and production of siderophores, cyanhydric acid (HCN) and indole-3-acetic acid. The strain was able to produce lytic enzymes, with an intense production of siderophores and to solubilize inorganic phosphate. Result of in vivo experiments indicated that the application of B8 at 107 CFU/mL, improved markedly the germination rate of rapeseed, whereas alfalfa seeds treated with the same strain showed a lower germination rate than the controls. The vegetative growth parameters; Roots length, lateral roots number, stem length, number of leaves, diameters of stems and plant weight were significantly improved. We also noted capacity of bacteria to colonize root systems of both plants B. napus and M. sativa in one week of inoculation. The overall results of this study showed that B clausii B8 has a great potential to be commercialized as a biostimulant agent and provide promising new option for sustainable agriculture.
Trichoderma species have been widely recognized as biofertilizer fungi for their ability to produce phytohormones and enhancing plant growth. In our current study, fifteen strains of Trichoderma spp (T1-T15) were screened for their capacity to produce phytohormones and metabolites eliciting plant growth. The stains were previously isolated from olive rhizosphere soil in northern Algeria. Plant growth promoting (PGP) potential of Trichoderma spp. was evaluated in-vitro through the production of phosphatases, iron chelators (siderophores), cyanhydric acid (HCN) and ammonia (NH3). Besides, Plant growth phytohormones such as gibberellic acid and indole-3-acetic acid (IAA) were assessed quantitatively by a colorimetric assay. Results showed an effective potential of Trichoderma isolates in PGP biomolecules production. Importantly, qualitative estimation of phosphate solubilization indicates that T10 gave the highest P-solubilization on medium Pikovskaya’s with a solubilization index (SI) of 3, whereas, the high capacity nitrogen-fixing was related to T8. In other hand, quantitative analysis of IAA and gibberellic acid revealed a production varying between (1.30 µg mL− 1 − 21.15 µg mL− 1) and (0.53µg/ml − 7.87µg/ml), respectively, the highest amount of both phytohormones was obtained by T11 isolate. Indeed, analysis of ethyl acetate extracts of T11 isolate by high-performance liquid chromatography (HPLC) revealed a high amount (71.19 mgL− 1) of IAA. Overall, Results showed clearly that isolate T11 has promising plant growth promoting properties. Hence, this native Trichoderma isolate (T11) identified as Trichoderma harzianum strain (OL587563) could be used later as biofertilizer for sustainable olive crop agriculture.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.